-
Featured Authors
Archive
- May 2013 (1)
- April 2013 (4)
- March 2013 (3)
- February 2013 (1)
- January 2013 (1)
- October 2012 (2)
- September 2012 (1)
- August 2012 (3)
- June 2012 (4)
- May 2012 (4)
- April 2012 (2)
- March 2012 (2)
- February 2012 (1)
- December 2011 (2)
- October 2011 (3)
- September 2011 (2)
- August 2011 (1)
- July 2011 (1)
- June 2011 (4)
- May 2011 (5)
- April 2011 (4)
- March 2011 (2)
- December 2010 (1)
- September 2010 (1)
- April 2010 (5)
- March 2010 (6)
- February 2010 (1)
- January 2010 (2)
Category Archives: The One-on-One Compass
#BIF2012 Company Snapshot: ContraFect Corporation
The BIO Investor Forum is fast approaching! Below you’ll find our first Company Snapshot of one of the event’s presenting companies, ContraFect Corporation. Continue reading to learn more about ContraFect’s product, their strategies, and what you can expect from their company in the coming months. Company Snapshot What is your company’s lead product or technology? ContraFect is a private company developing biotherapeutics for resistant, life threatening infections. Our lead compound, CF-301, is a bacteriophage lysin, Read More >





